search
Back to results

Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients (IAPV)

Primary Purpose

Neuromuscular Diseases

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Intermittent Abdominal Pressure Ventilation
Usual ventilation
Sponsored by
Fondazione Don Carlo Gnocchi Onlus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neuromuscular Diseases focused on measuring Neuromuscular Diseases;, Intermittent Abdominal Pressure Ventilation;, IAPV;

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of Neuromuscular Disease (Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Pompe Disease)
  • Non Invasive Ventilation > 16 hours/day
  • Informed consent signed

Exclusion Criteria:

- Diagnosis of kyphoscoliosis

Sites / Locations

  • IRCCS S. Maria Nascente - Fondazione Don Carlo GnocchiRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intermittent Abdominal Pressure Ventilation

Usual ventilation

Arm Description

Patients in experimental group will be adapted to Intermittent Abdominal Pressure Ventilation (IAPV). Abdominal ventilation replaces part of usual ventilation (non invasive ventilation with mouthpiece or nasal-pillow)

Patients in control group continue with usual ventilation (NIV through mouthpiece or nasal-pillow)

Outcomes

Primary Outcome Measures

Blood Gas Analysis
Changes of respiratory parameters in terms of normalization of oxyemia (Arterial Pressure of oxygen 80-100 mmHg) and normalization of capnia (Arterial Pressure of carbon dioxide 35-45 mmHg), assessed by blood gas analysis

Secondary Outcome Measures

Therapy adherence
Adherence to IAPV tested with Beliefs about Ventilation Questionnaire (BVQ). BVQ is a qualitative questionnaire: it consist of 25 items, where higher scores mean a better outcome.
Patients satisfaction to IAPV
Satisfaction to IAPV tested with Visual Analog Scale (VAS), with a score that ranges between 0 and 10, where a higher score means a worse outcome.
Caregivers satisfaction to IAPV
Satisfaction to IAPV tested with Visual Analog Scale (VAS), with a score that ranges between 0 and 10, where a higher score means a worse outcome.
Amelioration of Quality of life
Improvement of quality of life tested with World Health Organization Quality of Life-Brief (WHOQOL-Brief), with a score ranging from 0 to 100 for each of the four domain and where a higher score means a better outcome

Full Information

First Posted
April 13, 2022
Last Updated
December 15, 2022
Sponsor
Fondazione Don Carlo Gnocchi Onlus
search

1. Study Identification

Unique Protocol Identification Number
NCT05346263
Brief Title
Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients
Acronym
IAPV
Official Title
Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients: Multicentre, Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2022 (Actual)
Primary Completion Date
October 1, 2023 (Anticipated)
Study Completion Date
March 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondazione Don Carlo Gnocchi Onlus

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Non-Invasive Ventilation (NIV) is an established treatment to manage respiratory muscles dysfunction in neuromuscular disease, preventing the progression of respiratory failure to intubation and/or a tracheotomy. NIV is commonly needed at first during the night, but when the disease worsens, it is required during the day. It is provided via nasal or oronasal masks, causing discomfort and/or aesthetic issues that result in poor compliance. Intermittent Abdominal Pressure Ventilation (IAPV) is a valid, though unconventional, alternative to daytime NIV: it consists of a portable ventilator with an internal battery and a corset as interface. The IAPV corset is lightweight, comfortable and, thanks to velcro fasteners, easier and better fitting than a face mask. Cyclical inflation of a rubber bladder inside the corset moves the diaphragm upwards like a pneumobelt causing air to enter in the lungs via the upper airways as gravity draws the diaphragm back to its resting position. IAPV is indicated in neuromuscular disease and has already been tested in few preliminary studies and case reports. This study wants to verify the hypothesis of its application in population of neuromuscular patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Diseases
Keywords
Neuromuscular Diseases;, Intermittent Abdominal Pressure Ventilation;, IAPV;

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
78 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intermittent Abdominal Pressure Ventilation
Arm Type
Experimental
Arm Description
Patients in experimental group will be adapted to Intermittent Abdominal Pressure Ventilation (IAPV). Abdominal ventilation replaces part of usual ventilation (non invasive ventilation with mouthpiece or nasal-pillow)
Arm Title
Usual ventilation
Arm Type
Active Comparator
Arm Description
Patients in control group continue with usual ventilation (NIV through mouthpiece or nasal-pillow)
Intervention Type
Device
Intervention Name(s)
Intermittent Abdominal Pressure Ventilation
Other Intervention Name(s)
IAPV
Intervention Description
Patients of experimental group will use IAPV in daytime ventilation. Intermittent abdominal pressure ventilation (IAPV) is a portable ventilator with an internal battery and PneumoBelt corset as an interface.
Intervention Type
Device
Intervention Name(s)
Usual ventilation
Intervention Description
NIV
Primary Outcome Measure Information:
Title
Blood Gas Analysis
Description
Changes of respiratory parameters in terms of normalization of oxyemia (Arterial Pressure of oxygen 80-100 mmHg) and normalization of capnia (Arterial Pressure of carbon dioxide 35-45 mmHg), assessed by blood gas analysis
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Therapy adherence
Description
Adherence to IAPV tested with Beliefs about Ventilation Questionnaire (BVQ). BVQ is a qualitative questionnaire: it consist of 25 items, where higher scores mean a better outcome.
Time Frame
12 months
Title
Patients satisfaction to IAPV
Description
Satisfaction to IAPV tested with Visual Analog Scale (VAS), with a score that ranges between 0 and 10, where a higher score means a worse outcome.
Time Frame
12 months
Title
Caregivers satisfaction to IAPV
Description
Satisfaction to IAPV tested with Visual Analog Scale (VAS), with a score that ranges between 0 and 10, where a higher score means a worse outcome.
Time Frame
12 months
Title
Amelioration of Quality of life
Description
Improvement of quality of life tested with World Health Organization Quality of Life-Brief (WHOQOL-Brief), with a score ranging from 0 to 100 for each of the four domain and where a higher score means a better outcome
Time Frame
12 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Neuromuscular Disease (Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Pompe Disease) Non Invasive Ventilation > 16 hours/day Informed consent signed Exclusion Criteria: - Diagnosis of kyphoscoliosis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Paolo Banfi, MD
Phone
00390240308812
Email
pabanfi@dongnocchi.it
First Name & Middle Initial & Last Name or Official Title & Degree
Valeria Volpi, PT
Email
vvolpi@dongnocchi.it
Facility Information:
Facility Name
IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
City
Milan
ZIP/Postal Code
20146
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paolo Banfi, MD
Phone
+390240308812
Email
pabanfi@dongnocchi.it

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients

We'll reach out to this number within 24 hrs